Free NABP NAPLEX Practice Exam with Questions & Answers | Set: 2

80kg person = 15mg/kg/day = 1200mg/day 80mg /5ml = 1200mg/X X= 75mL/day / 4 doses = 18.75 mL per dose

Pancreatitis is one of the most serious adverse effects that can be caused by valproic acid. Gingival hyperplasia is a side effect of Phenytoin. Kidney stones and weight loss can be a side effect of zonisamide or topiramate.

A type III hypersensitivity reaction is mediated by immune complex deposition. In lupus, auto-antibodies are formed and these complexes are deposited in other tissues, especially in the kidneys, skin, and joints. Graves disease and myasthenia gravis are examples of type II but in some classification systems they are called type V reactions. The auto-antibodies created in Graves attack TSH receptors in the thyroid, whereas in

Myasthenia the target is the acetylcholine receptor. Hashimoto’s thyroiditis is usually considered an example of a combination of type II and IV reactions, as T cells are directed at thyroid antigens and antibodies are also produced. Allergic rhinitis is a classic example of a type I, IgE mediated reaction.

Pregabalin is the active ingredient of the medicine Lyrica; a drug used to treat epilepsy, neuropathic pain, fibromyalgia and generalized anxiety disorder (GAD).

Since the bioavailability of levothyroxine is roughly 50% (given in the QUESTION NO:). To convert the home dose to intravenous, it would be 50% of the oral dose. So 50% of oral 75 mcg would be 37.5 mcg intravenously.

Pregabalin works as a ligand of the auxiliary α2δ subunit site of certain voltage-dependent calcium channels (VDCCs), and thereby acts as an inhibitor of α2δ subunit-containing VDCCs.

Corrected phenytoin (mg/L) = Observed phenytoin (mg/L) / (0.2 x albumin [g/dL]) + 0.1 = 17.8 / (0.2 x 2.1) +

0.1 = 17.8 / 0.42 + 0.1 = 42.48mg/L ← phenytoin level is high. Normal therapeutic range is: 10-20mg/dL

SG= weight/mL, 1.27 = x/1000ml, x = 1270gm

Nadolol is not proven to reduce mortality in patients with systolic CHF. The efficacy of nadolol in HF has not been determined. For patients taking nadolol, it should be used with caution in those with compensated heart failure and patients should be monitored for a worsening of the condition. Bisoprolol, carvedilol, and sustained- release metoprolol succinate are the beta-blockers that have been proven to reduce mortality in patients with systolic CHF. These 3 beta-blockers have been effective in reducing the risk of death in patients with chronic HFrEF. Other beta-blockers were found to be less effective. Bucindolol did not exhibit uniform effectiveness across different populations. Metoprolol tartrate was found to be less effective in HF clinical trials.

Section: (none)

Explanation

Dapsone treatment has produced dose-related hemolysis and hemolytic anemia. Individuals with glucose-6¬ phosphate dehydrogenase (G6PD) deficiency are more prone to hemolysis.